Trial intelligence / Profile preview

Bromocriptine vs metformin in polycystic ovary syndrome

ChiCTR2500107757Phase 4Recruiting

Sponsor
Sir Run-Run Shaw Hospital
Start
Aug 2025
Modality
Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 4 trial of bromocriptine and metformin in polycystic ovary syndrome (PCOS) (4 arms), sponsored by Sir Run-Run Shaw Hospital. Primary endpoints: Full set of sex hormones, Anti-Müllerian hormone and 6 more. Started Aug 2025; status: recruiting.

02

Drugs

bromocriptinemetformin
03

Conditions

polycystic ovary syndrome (PCOS)

Beyond the preview

Go deeper on ChiCTR2500107757.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2500107757.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call